Health-related quality of life (HRQoL) outcomes with darolutamide in the phase 3 ARANOTE trial. A multicenter, randomized, phase 2, investigator-initiated ETCTN trial of olaparib + radium-223 vs.

The forecast range in this table is based on algorithmic projections provided by Changelly. These models use historical price trends, volatility patterns, and moving averages to estimate future ...